Compared to HC, r/r DLBCL patients presented with significantly more activated HLA-DR-expressing PB T cells, indicating cellular activation and/or homeostatic proliferation (36), as well as pathologically increased, frequencies of CD3+CD27-CD28- T cells. The gene discussed is CD28; the disease is diffuse large B-cell lymphoma.